Inflammation-sensitive plasma proteins are associated with future weight gain

Diabetes

Volumn 52, Issue 8, 2003, Pages 2097-2101

  Engström, Gunnar ^a,b   Hedblad, Bo ^a   Stavenow, Lars ^a   Lind, Peter ^a   Janzon, Lars ^a   Lindgärde, Folke ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CERULOPLASMIN; FIBRINOGEN; HAPTOGLOBIN; OROSOMUCOID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; INSULIN RESISTANCE; MALE; NORMAL HUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SMOKING; WEIGHT GAIN;

ADULT; ALPHA 1-ANTITRYPSIN; CERULOPLASMIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FIBRINOGEN; FOLLOW-UP STUDIES; HAPTOGLOBINS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; OROSOMUCOID; PREDICTIVE VALUE OF TESTS; RISK FACTORS; WEIGHT GAIN;

EID: 0042767562     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.8.2097     Document Type: Article

References (43)

1. Lind P, Hedblad B, Stavenow L, Janzon L, Eriksson KF, Lindgärde F: Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: a long-term cohort study. Arterioscler Thromb Vasc Biol 21:452-458, 2001
2. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM: The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25:1407-1415, 2001
3. Ford ES: Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22:1971-1977, 1999
4. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978, 1999
5. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T: TNF-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 83:2907-2910, 1998
6. Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, Prabhala A, Afzal A, Garg R: The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 86:355-362, 2001
7. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET: Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105:564-569, 2002
8. Trayhurn P, Beattie JH: Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60:329-339, 2001
9. Coppack SW: Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60:349-356, 2001
10. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209-214, 2000
11. Das UN: Is obesity an inflammatory condition? Nutrition 17:953-966, 2001
12. Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Carpenter M, Heiss G: Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults: the ARIC study. Obes Res 8:279-286, 2000
13. Engström G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgärde F: Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke 33:2744-2749, 2002
14. Engström G, Stavenow L, Hedblad B, Lind P, Eriksson K-F, Janzon L, Lindgärde F: Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 52:442-447, 2003
15. Engström G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgärde F: The effects of cholesterol and inflammation-sensitive proteins on incidence of stroke and myocardial infarction. Circulation 105:2632-2637, 2002
16. Engström G, Janzon L, Berglund G, Lind P, Stavenow L, Hedblad B, Lindgärde F: Blood pressure increase and incidence of hypertension in relation to inflammation sensitive plasma proteins. Arterioscl Thromb Vasc Biol 22:2054-2058, 2002
17. Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, Lindgärde F: Long-term outcome of the Malmö Preventive Project: mortality and cardiovascular morbidity. J Intern Med 247:19-29, 2000
18. Thorell JI, Larson SM: Radioimmunoassay and Related Techniques: Methodology and Clinical Applications. St. Louis, MO, CV Mosby, 1978, p. 205-211
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
20. Kristenson H, Trell E: Indicators of alcohol consumption: comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males. Br J Addict 77:297-304, 1982
21. Laurell CB: Electroimmuno assay. Scand J Clin Lab Invest Suppl 124:21-37, 1972
22. Ford ES: Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidmiology 13:561-568, 2002
23. Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R, Dandona P: Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 75:767-772, 2002
24. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P: Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85:2970-2973, 2000
25. Yasunari K, Maeda K, Nakamura M, Yoshikawa J: Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension 39:777-780, 2002
26. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM: Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 75:492-498, 2002
27. Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 107:391-397, 2003
28. Hotamisligil GS: The role of TNF-α and TNF receptors in obesity and insulin resistance. J Intern Med 245:621-625, 1999
29. Pickup JC, Crook MA: Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41:1241-1248, 1998
30. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334, 2001
31. Festa A, D'Agostino R Jr., Tracy RP, Haffner SM: Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 51:1131-1137, 2002
32. Moshage H: Cytokines and the hepatic acute phase response. J Pathol 181:257-266, 1997
33. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454, 1999
34. Aljada A, Ghanim H, Assian E, Dandona P: Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism 51:487-491, 2002
35. Bruun JM, Pedersen SB, Kristensen K, Richelsen B: Effects of proinflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol 190:91-99, 2002
36. Meguid MM, Fetissov SO, Varma M, Sato T, Zhang L, Laviano A, Rossi-Fanelli F: Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 16:843-857, 2000
37. Fernandez-Real JM, Vendrell J, Ricart W, Broch M, Gutierrez C, Casamitjana R, Oriola J, Richart C: Polymorphism of the tumor necrosis factor-α receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care 23:831-837, 2000
38. Björntorp P: Do stress reactions cause abdominal obesity and comorbidities? Obes Rev 2:73-86, 2001
39. Leal-Cerro A, Soto A, Martinez MA, Dieguez C, Casanueva FF: Influence of cortisol status on leptin secretion. Pituitary 4:111-116, 2001
40. Udden J, Björntorp P, Arner P, Barkeling B, Meurling L, Rössner S: Effects of glucocorticoids on leptin levels and eating behaviour in women. J Intern Med 253:225-231, 2003
41. Haddad JJ, Saade NE, Safleh-Garabedian B: Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol 133:1-19, 2002
42. Ottosson M, Lönnroth P, Björntorp P, Eden S: Effects of cortisol and growth hormone on lipolysis in human adipose tissue. J Clin Endocrinol Metab 85:799-803, 2000
43. Lopez-Calderon A, Soto L, Martin AI: Chronic inflammation inhibits GH secretion and alters the serum insulin-like growth factor system in rats. Life Sci 65:2049-2060, 1999